INMB - INmune Bio GAAP EPS of -$0.36 beats by $0.04 August, 07 2023 04:41 PM INmune Bio Inc. 2023-08-07 16:41:20 ET INmune Bio press release ( NASDAQ: INMB ): Q2 GAAP EPS of -$0.36 beats by $0.04 . As of June 30, 2023, the Company had cash and cash equivalents of approximately $47.8 million. For further details see: INmune Bio GAAP EPS of -$0.36 beats by $0.04